ELTX
Elicio Therapeutics, Inc.
Company overview
- Market capitalization
- $48.62M
- Employees
- 33
- Latest publication
- 2026-09-29
About Elicio Therapeutics, Inc.
Elicio Therapeutics, Inc., a clinical-stage biotechnology company, develops immunotherapies for the treatment of cancer. Its lead product candidate, ELI-002, is a multivalent lymph node-targeted amphiphile (AMP) peptide vaccine that is in Phase II clinical trials for seven Kirsten rat sarcoma viral oncogene homolog driver mutations. The company also develops ELI-007, a multivalent lymph node-targeted AMP peptide treatment for mutant b-raf murine sarcoma viral oncogene homolog B1-(BRAF) driven cancers, and ELI-008, a multivalent lymph node-targeted AMP peptide vaccine in preclinical studies for the treatment of mutated tumor protein p53-expressing cancers. Elicio Therapeutics, Inc. is headquartered in Boston, Massachusetts.
Financial statements
Income Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 0USD | 0USD | 0USD | 1,166,000USD | 0USD | 0USD |
| Cost Of Revenue | 289,000USD | 286,000USD | 283,000USD | 281,000USD | 278,000USD | 305,000USD | 290,000USD | 293,000USD |
| Gross Profit | -289,000USD | -286,000USD | -283,000USD | -281,000USD | -278,000USD | -305,000USD | -290,000USD | -293,000USD |
| Research Development | 6,711,000USD | 5,080,000USD | 5,039,000USD | 7,006,000USD | 7,778,000USD | 10,624,000USD | 7,208,000USD | 8,180,000USD |
| Selling General Administrative | 3,845,000USD | 3,762,000USD | 3,006,000USD | 3,085,000USD | 2,958,000USD | 2,767,000USD | 3,136,000USD | 2,744,000USD |
| Total Operating Expenses | 10,313,000USD | 8,842,000USD | 8,045,000USD | 10,091,000USD | 10,458,000USD | 13,171,000USD | 10,054,000USD | 10,631,000USD |
| Operating Income | -10,602,000USD | -8,842,000USD | -8,045,000USD | -10,091,000USD | -10,736,000USD | -13,476,000USD | -10,344,000USD | -10,924,000USD |
| Interest Income | 157,000USD | 199,000USD | 199,000USD | 168,000USD | 210,000USD | 305,000USD | 185,000USD | 137,000USD |
| Interest Expense | 407,000USD | 337,000USD | 426,000USD | 194,000USD | 176,000USD | 234,000USD | 137,000USD | 49,000USD |
| Net Interest Income | -250,000USD | -138,000USD | -227,000USD | -26,000USD | 34,000USD | 71,000USD | -2,876,000USD | 88,000USD |
| Income Before Tax | -11,823,000USD | -7,718,000USD | -10,083,000USD | -10,561,000USD | -11,209,000USD | -14,004,000USD | -18,838,000USD | -7,229,000USD |
| Net Income | -11,823,000USD | -7,718,000USD | -10,083,000USD | -10,561,000USD | -11,209,000USD | -14,004,000USD | -18,838,000USD | -7,229,000USD |
| Net Income From Continuing Ops | -11,823,000USD | -7,718,000USD | -10,083,000USD | -10,561,000USD | -11,209,000USD | -14,004,000USD | -18,838,000USD | -7,229,000USD |
| Ebit | -11,416,000USD | -7,381,000USD | -9,657,000USD | -10,367,000USD | -11,033,000USD | -13,770,000USD | -18,701,000USD | -7,180,000USD |
| Ebitda | -11,127,000USD | -7,095,000USD | -9,374,000USD | -10,086,000USD | -10,755,000USD | -13,465,000USD | -18,411,000USD | -6,887,000USD |
| Depreciation And Amortization | 289,000USD | 286,000USD | 283,000USD | 281,000USD | 278,000USD | 305,000USD | 290,000USD | 293,000USD |
| Reconciled Depreciation | 289,000USD | 286,000USD | 283,000USD | 281,000USD | 278,000USD | 305,000USD | 290,000USD | 293,000USD |
| Total Other Income Expense Net | -1,221,000USD | 1,124,000USD | -2,038,000USD | -470,000USD | -473,000USD | -528,000USD | -8,494,000USD | 3,695,000USD |
| Income Tax Expense | — | — | — | — | — | -36,000USD | — | — |
| Selling And Marketing Expenses | — | — | — | — | — | — | — | 213,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20182018-12-31 · USD | FY 20132013-12-31 · USD | FY 20122012-12-31 · USD |
|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 0USD | 4,029,000USD | 6,581,072USD | 7,297,701USD |
| Cost Of Revenue | 1,128,000USD | 1,178,000USD | 1,170,000USD | 380,000USD | 3,173,478USD | 3,673,684USD |
| Gross Profit | -1,128,000USD | -1,178,000USD | -1,170,000USD | 3,649,000USD | 3,407,594USD | 3,624,017USD |
| Research Development | 24,903,000USD | 33,656,000USD | 22,679,000USD | 9,151,000USD | 196,008USD | — |
| Selling General Administrative | 12,811,000USD | 11,330,000USD | 11,896,000USD | — | — | — |
| Unclassified Operating Expenses | -1,128,000USD | -1,178,000USD | — | 8,840,000USD | 3,609,386USD | 4,043,234USD |
| Total Operating Expenses | 36,586,000USD | 43,808,000USD | 34,575,000USD | 17,991,000USD | 3,805,394USD | 4,043,234USD |
| Operating Income | -37,714,000USD | -44,986,000USD | -35,745,000USD | -14,342,000USD | -397,800USD | -419,220USD |
| Interest Income | 776,000USD | 777,000USD | 373,000USD | — | — | — |
| Interest Expense | 1,133,000USD | 455,000USD | 1,059,000USD | — | 300,432USD | 307,450USD |
| Net Interest Income | -357,000USD | -3,180,000USD | -686,000USD | — | — | — |
| Income Before Tax | -39,571,000USD | -51,898,000USD | -35,195,000USD | -20,025,000USD | 1,732,434USD | 1,193,973USD |
| Tax Provision | 0USD | 0USD | 0USD | — | — | — |
| Net Income | -39,571,000USD | -51,898,000USD | -35,195,000USD | -20,025,000USD | 632,241USD | 307,303USD |
| Net Income From Continuing Ops | -39,571,000USD | -51,898,000USD | -35,195,000USD | — | — | — |
| Ebit | -38,438,000USD | -51,443,000USD | -34,136,000USD | -14,342,000USD | -397,804USD | 1,501,423USD |
| Ebitda | -37,310,000USD | -50,265,000USD | -32,966,000USD | -14,340,000USD | 62,540USD | 1,964,639USD |
| Depreciation And Amortization | 1,128,000USD | 1,178,000USD | 1,170,000USD | 2,000USD | 460,344USD | 463,216USD |
| Reconciled Depreciation | 1,128,000USD | 1,178,000USD | 1,170,000USD | — | — | — |
| Total Other Income Expense Net | -1,857,000USD | -6,912,000USD | 550,000USD | -5,683,000USD | 2,130,234USD | 1,613,190USD |
| Income Tax Expense | — | — | — | — | 452,778USD | 201,858USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 31,330,000USD | 22,689,000USD | 25,862,000USD | 28,284,000USD | 29,528,000USD | 28,144,000USD | 28,178,000USD | 38,388,000USD |
| Cash And Equivalents | 23,480,000USD | — | — | — | — | — | — | — |
| Total Current Assets | 25,485,000USD | 16,200,000USD | 19,311,000USD | 21,465,000USD | 22,598,000USD | 20,935,000USD | 20,693,000USD | 30,646,000USD |
| Other Current Assets | 2,005,000USD | 1,252,000USD | 748,000USD | 854,000USD | 510,000USD | 2,584,000USD | 3,075,000USD | 4,628,000USD |
| Total Liabilities | 23,393,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 9,202,000USD | 7,229,000USD | 8,110,000USD | 6,515,000USD | 9,923,000USD | 11,413,000USD | 11,523,000USD | 9,020,000USD |
| Other Current Liabilities | 7,290,000USD | — | — | — | — | — | — | — |
| Total Stockholder Equity | 7,937,000USD | -1,437,000USD | 1,636,000USD | 3,816,000USD | 1,834,000USD | 8,904,000USD | -11,312,000USD | -18,986,000USD |
| Total Equity Including Noncontrolling Interest | 7,937,000USD | — | — | — | — | — | — | — |
| Long Term Debt | 9,535,000USD | 9,475,000USD | 9,407,000USD | 9,720,000USD | 9,337,000USD | — | 20,034,000USD | 19,835,000USD |
| Property Plant Equipment Net | 4,505,000USD | 4,788,000USD | 5,077,000USD | 5,347,000USD | 5,630,000USD | 5,911,000USD | 6,189,000USD | 6,449,000USD |
| Accounts Payable | 839,000USD | 272,000USD | 672,000USD | 321,000USD | 3,865,000USD | 4,037,000USD | 1,038,000USD | 1,984,000USD |
| Short Term Debt | 1,073,000USD | 1,042,000USD | 1,011,000USD | 981,000USD | 952,000USD | 926,000USD | 901,000USD | 877,000USD |
| Common Stock | 219,000USD | 186,000USD | 178,000USD | 173,000USD | 163,000USD | 160,000USD | 110,000USD | 108,000USD |
| Retained Earnings | -253,712,000USD | -245,495,000USD | -233,672,000USD | -225,954,000USD | -215,871,000USD | -205,310,000USD | -194,101,000USD | -180,097,000USD |
| Accumulated Other Comprehensive Income | -126,000USD | -122,000USD | -127,000USD | -31,000USD | -70,000USD | -144,000USD | -175,000USD | -202,000USD |
| Total Liab | — | 24,126,000USD | 24,226,000USD | 24,468,000USD | 27,694,000USD | 19,240,000USD | 39,490,000USD | 57,374,000USD |
| Other Current Liab | — | 5,915,000USD | 6,427,000USD | 5,213,000USD | 5,106,000USD | 6,450,000USD | 8,415,000USD | 6,159,000USD |
| Capital Stock | — | 186,000USD | 178,000USD | 173,000USD | 163,000USD | 160,000USD | 110,000USD | 108,000USD |
| Cash | — | 14,948,000USD | 18,563,000USD | 20,611,000USD | 22,088,000USD | 18,351,000USD | 17,618,000USD | 26,016,000USD |
| Cash And Short Term Investments | — | 14,948,000USD | 18,563,000USD | 20,611,000USD | 22,088,000USD | 18,351,000USD | 17,618,000USD | 26,016,000USD |
| Net Debt | — | -608,000USD | -4,051,000USD | -5,554,000USD | -7,186,000USD | -12,560,000USD | 8,422,000USD | 34,000USD |
| Short Long Term Debt Total | — | 14,340,000USD | 14,512,000USD | 15,057,000USD | 14,902,000USD | 5,791,000USD | 26,040,000USD | 26,050,000USD |
| Property Plant Equipment Gross | — | 6,590,000USD | 6,833,000USD | 7,054,000USD | 7,288,000USD | 7,516,000USD | 7,741,000USD | 7,916,000USD |
| Common Stock Shares Outstanding | — | 18,211,745shares | 15,312,751shares | 16,692,476shares | 16,059,423shares | 12,950,574shares | 12,202,996shares | 13,582,345shares |
| Non Current Assets Total | — | 6,489,000USD | 6,551,000USD | 6,819,000USD | 6,930,000USD | 7,209,000USD | 7,485,000USD | 7,742,000USD |
| Non Current Liabilities Total | — | 16,897,000USD | 16,116,000USD | 17,953,000USD | 17,771,000USD | 7,827,000USD | 27,967,000USD | 48,354,000USD |
| Non Currrent Assets Other | — | 1,701,000USD | 770,000USD | 1,472,000USD | 600,000USD | 1,298,000USD | 600,000USD | 1,293,000USD |
| Net Working Capital | — | 8,971,000USD | 11,201,000USD | 14,950,000USD | 12,675,000USD | 9,522,000USD | 9,170,000USD | 21,626,000USD |
| Unclassified Non Current Liabilities | — | 7,422,000USD | 6,709,000USD | 8,233,000USD | 8,434,000USD | 7,827,000USD | 7,933,000USD | 28,519,000USD |
| Unclassified Equity | — | 243,808,000USD | 235,079,000USD | 229,455,000USD | 217,449,000USD | 214,038,000USD | 182,744,000USD | 161,097,000USD |
| Current Deferred Revenue | — | — | — | — | — | — | 1,169,000USD | — |
| Net Receivables | — | — | — | — | — | — | — | 2,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 25,862,000USD | 28,178,000USD | 27,146,000USD | 22,664,000USD | 96,513,000USD | 47,347,000USD | 11,886,000USD | 26,628,000USD |
| Other Current Assets | 748,000USD | 3,075,000USD | 3,454,000USD | 2,920,000USD | 1,685,000USD | 712,000USD | 95,000USD | 60,000USD |
| Total Liab | 24,226,000USD | 39,490,000USD | 15,773,000USD | 13,749,000USD | 15,006,000USD | 137,796,000USD | 30,472,000USD | 7,717,000USD |
| Total Stockholder Equity | 1,636,000USD | -11,312,000USD | 11,373,000USD | 8,915,000USD | 81,507,000USD | -90,449,000USD | -18,586,000USD | 18,911,000USD |
| Other Current Liab | 6,427,000USD | 8,415,000USD | 4,476,000USD | 1,935,000USD | 3,333,000USD | 17,369,000USD | 8,455,000USD | 6,802,000USD |
| Common Stock | 178,000USD | 110,000USD | 96,000USD | 3,000USD | 300,000USD | 156,000USD | 95,000USD | 94,000USD |
| Capital Stock | 178,000USD | 110,000USD | 96,000USD | 176,993USD | 171,426USD | 130,617USD | 39,725USD | — |
| Retained Earnings | -233,672,000USD | -194,101,000USD | -142,203,000USD | -107,008,000USD | -215,135,000USD | -160,562,000USD | -80,455,000USD | -39,797,000USD |
| Cash | 18,563,000USD | 17,618,000USD | 12,894,000USD | 7,797,000USD | 88,756,000USD | 34,607,000USD | 5,571,000USD | 25,512,000USD |
| Cash And Short Term Investments | 18,563,000USD | 17,618,000USD | 12,894,000USD | 7,797,000USD | 88,756,000USD | 34,607,000USD | 5,571,000USD | 25,512,000USD |
| Total Current Assets | 19,311,000USD | 20,693,000USD | 16,348,000USD | 10,717,000USD | 91,247,000USD | 40,319,000USD | 6,106,000USD | 25,679,000USD |
| Total Current Liabilities | 8,110,000USD | 11,523,000USD | 9,755,000USD | 6,868,000USD | 11,296,000USD | 107,449,000USD | 26,575,000USD | 7,355,000USD |
| Net Debt | -4,051,000USD | 8,422,000USD | -5,977,000USD | -316,000USD | -84,094,000USD | 50,435,000USD | 5,207,000USD | -25,512,000USD |
| Short Term Debt | 1,011,000USD | 901,000USD | 910,000USD | 692,000USD | 952,000USD | 80,560,000USD | 6,881,000USD | — |
| Short Long Term Debt Total | 14,512,000USD | 26,040,000USD | 6,917,000USD | 7,481,000USD | 4,662,000USD | 85,042,000USD | 10,778,000USD | — |
| Long Term Debt | 9,407,000USD | 20,034,000USD | — | — | — | — | — | — |
| Accounts Payable | 672,000USD | 1,038,000USD | 4,369,000USD | 2,805,000USD | 4,710,000USD | 5,578,000USD | 11,239,000USD | 534,000USD |
| Property Plant Equipment Net | 5,077,000USD | 6,189,000USD | 7,280,000USD | 8,497,000USD | 4,437,000USD | 4,228,000USD | 4,781,000USD | 17,000USD |
| Property Plant Equipment Gross | 6,833,000USD | 7,741,000USD | 8,511,000USD | 9,618,957USD | 1,649,179USD | 1,531,731USD | 1,742,245USD | — |
| Accumulated Other Comprehensive Income | -127,000USD | -175,000USD | -197,000USD | -111,060,000USD | -103,000USD | -333,000USD | -313,928USD | — |
| Common Stock Shares Outstanding | 15,312,751shares | 12,202,996shares | 5,056,225shares | 3,100,000shares | 3,200,000shares | 8,150,000shares | 8,150,000shares | 2,948,449shares |
| Non Current Assets Total | 6,551,000USD | 7,485,000USD | 10,798,000USD | 11,947,000USD | 5,266,000USD | 7,028,000USD | 5,779,999USD | 949,000USD |
| Non Current Liabilities Total | 16,116,000USD | 27,967,000USD | 6,018,000USD | 6,881,000USD | 3,710,000USD | 30,347,000USD | 3,897,000USD | 362,000USD |
| Non Currrent Assets Other | 1,474,000USD | 600,000USD | 3,518,000USD | 2,833,000USD | 106,000USD | 1,978,000USD | -843,901USD | — |
| Net Working Capital | 11,201,000USD | 9,170,000USD | 6,582,000USD | 3,848,604USD | -8,519,781USD | 12,145,443USD | 5,505,918USD | — |
| Unclassified Non Current Liabilities | 6,709,000USD | 7,933,000USD | 6,018,000USD | 6,697,000USD | 3,650,500USD | 30,347,000USD | 3,897,000USD | — |
| Unclassified Equity | 235,079,000USD | 182,744,000USD | 153,581,000USD | 226,803,007USD | 296,273,574USD | 70,159,383USD | 62,048,203USD | 58,614,000USD |
| Current Deferred Revenue | — | 1,169,000USD | 694,000USD | 1,436,000USD | 2,301,000USD | 3,942,000USD | -428,176USD | 19,000USD |
| Other Liab | — | — | — | 92,000USD | 29,750USD | — | — | — |
| Other Assets | — | — | — | 3,451,016USD | -3,000USD | 3,184,729USD | 155,099USD | — |
| Inventory | — | — | — | 4,219,838USD | 188,957USD | -4,621,291USD | -63,707USD | — |
| Non Current Liabilities Other | — | — | — | 92,000USD | 29,750USD | — | — | — |
| Net Tangible Assets | — | — | — | -102,145,395USD | -74,536,296USD | -49,139,518USD | -34,898,211USD | — |
| Unclassified Current Assets | — | — | — | -4,219,838USD | — | — | — | — |
| Unclassified Non Current Assets | — | — | — | -2,834,016USD | — | -2,362,729USD | — | — |
| Short Long Term Debt | — | — | — | — | 11,797,071USD | — | — | — |
| Net Receivables | — | — | — | — | 806,000USD | 5,000,000USD | 440,000USD | 107,000USD |
| Unclassified Current Liabilities | — | — | — | — | -11,797,071USD | — | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow YTD
| Metric | Q2 20262026-06-30 · USD |
|---|---|
| Depreciation | 82,000USD |
| Stock Based Compensation | 1,803,000USD |
| Change To Liabilities | 167,000USD |
| Change In Working Capital | -1,145,000USD |
| Operating Cash Flow | -19,810,000USD |
| Financing Cash Flow | 24,537,000USD |
| Effect Of Forex Changes On Cash | 1,000USD |
| Change In Cash | 4,728,000USD |
| End Cash Flow | 23,995,000USD |
| Source | DisclosureDeterministicFinal |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -11,823,000USD | -7,718,000USD | -10,083,000USD | -10,561,000USD | -11,209,000USD | -14,004,000USD | -18,838,000USD | -7,229,000USD |
| Depreciation | 289,000USD | 286,000USD | 283,000USD | 281,000USD | 278,000USD | 305,000USD | 290,000USD | 293,000USD |
| Stock Based Compensation | 868,000USD | 772,000USD | 698,000USD | 710,000USD | 517,000USD | 464,000USD | 327,000USD | 350,000USD |
| Other Non Cash Items | 1,052,000USD | -1,576,000USD | 2,195,000USD | 971,000USD | 649,000USD | 806,000USD | 9,169,000USD | -3,616,000USD |
| Change In Working Capital | -2,031,000USD | 1,439,000USD | -4,179,000USD | -351,000USD | -354,000USD | 3,685,000USD | 1,762,000USD | 1,274,000USD |
| Total Cash From Operating Activities | -11,645,000USD | -6,797,000USD | -11,086,000USD | -8,950,000USD | -10,119,000USD | -8,744,000USD | -7,274,000USD | -8,928,000USD |
| Capital Expenditures | 0USD | -16,000USD | 0USD | 0USD | 0USD | -45,000USD | -42,000USD | -42,000USD |
| Free Cash Flow | -11,645,000USD | -6,813,000USD | -11,086,000USD | -8,950,000USD | -10,119,000USD | -8,789,000USD | -7,274,000USD | -8,970,000USD |
| Total Cash From Financing Activities | 8,026,999USD | 4,863,000USD | 9,572,000USD | 11,932,000USD | 10,328,000USD | 227,000USD | 30,754,000USD | 316,000USD |
| Issuance Of Capital Stock | 7,988,000USD | 4,859,000USD | 8,534,000USD | 2,016,000USD | 9,978,000USD | 222,000USD | 48,000USD | 303,000USD |
| Change In Cash | -3,615,000USD | -2,046,000USD | -1,477,000USD | 3,056,000USD | 240,000USD | -8,535,000USD | 23,516,000USD | -8,695,000USD |
| Begin Period Cash Flow | 18,563,000USD | 21,313,000USD | 22,088,000USD | 19,732,000USD | 19,492,000USD | 28,027,000USD | 4,511,000USD | 13,206,000USD |
| End Period Cash Flow | 14,948,000USD | 19,267,000USD | 20,611,000USD | 22,788,000USD | 19,732,000USD | 19,492,000USD | 28,027,000USD | 4,511,000USD |
| Other Cashflows From Financing Activities | -61,000USD | 4,863,000USD | 9,572,000USD | 9,916,000USD | 1,185,000USD | 5,000USD | 10,979,000USD | 13,000USD |
| Total Cashflows From Investing Activities | — | -16,000USD | — | — | — | -45,000USD | -42,000USD | -42,000USD |
| Net Borrowings | — | -9,866,000USD | 0USD | — | — | 0USD | 19,727,000USD | — |
| Unclassified Financing Cash Flow | — | 5,007,000USD | -8,534,000USD | — | — | — | — | — |
| Investments | — | — | 0USD | 0USD | 0USD | -45,000USD | 0USD | -42,000USD |
| Other Cashflows From Investing Activities | — | — | — | — | — | 45,000USD | 42,000USD | 3,000USD |
| Sale Purchase Of Stock | — | — | — | — | — | — | 0USD | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -39,571,000USD | -51,898,000USD | -35,195,000USD | -28,208,000USD | -26,400,697USD | -80,107,000USD | -40,658,000USD | -20,025,000USD |
| Depreciation | 1,128,000USD | 1,178,000USD | 1,170,000USD | 1,057,000USD | 251,451USD | 628,000USD | 496,000USD | 2,000USD |
| Stock Based Compensation | 2,697,000USD | 1,452,000USD | 1,179,000USD | 579,000USD | 617,756USD | 304,468USD | 145,081USD | — |
| Other Non Cash Items | 2,239,000USD | 8,241,000USD | 209,000USD | 4,543,000USD | 667,048USD | 30,822,000USD | 5,823,000USD | 8,290,000USD |
| Change In Working Capital | -3,445,000USD | 3,959,000USD | -57,000USD | -150,000USD | 872,435USD | 25,769,000USD | 9,750,000USD | 3,088,000USD |
| Total Cash From Operating Activities | -36,952,000USD | -37,068,000USD | -32,694,000USD | -22,179,000USD | -23,939,045USD | -22,888,000USD | -24,589,000USD | -8,020,000USD |
| Capital Expenditures | -16,000USD | -87,000USD | -66,000USD | -654,000USD | -525,359USD | -41,000USD | -242,000USD | 0USD |
| Free Cash Flow | -36,968,000USD | -37,155,000USD | -32,760,000USD | -22,833,000USD | -24,464,404USD | -22,929,000USD | -24,831,000USD | -8,020,000USD |
| Total Cashflows From Investing Activities | -16,000USD | -84,000USD | -32,000USD | -654,000USD | -525,359USD | -41,000USD | -242,000USD | — |
| Net Borrowings | 0USD | 19,727,000USD | 10,000,000USD | 0USD | 14,680,604USD | 14,680,604USD | 14,680,604USD | — |
| Total Cash From Financing Activities | 36,695,000USD | 42,321,000USD | 38,613,000USD | 21,202,000USD | 19,393,568USD | 52,409,000USD | 4,890,000USD | 31,741,000USD |
| Issuance Of Capital Stock | 25,387,000USD | 5,635,000USD | 6,999,000USD | 21,119,998USD | 5,046,680USD | 24,815,733USD | 6,299,640USD | — |
| Change In Cash | -233,000USD | 5,191,000USD | 5,887,000USD | -1,631,000USD | -5,070,836USD | 29,036,000USD | -19,941,000USD | 23,454,751USD |
| Begin Period Cash Flow | 19,492,000USD | 14,301,000USD | 8,414,000USD | 10,045,000USD | 15,115,346USD | 5,571,000USD | 25,512,000USD | 2,057,249USD |
| End Period Cash Flow | 19,267,000USD | 19,492,000USD | 14,301,000USD | 8,414,000USD | 10,044,510USD | 34,607,000USD | 5,571,000USD | 25,512,000USD |
| Other Cashflows From Financing Activities | 36,695,000USD | 16,959,000USD | 21,764,000USD | 21,202,000USD | 5,260,179USD | -7,056,682USD | 12,968,634USD | — |
| Unclassified Financing Cash Flow | -25,387,000USD | 6,184,000USD | 6,999,000USD | — | -5,593,895USD | 44,821,078USD | -22,384,238USD | — |
| Investments | — | -84,000USD | -32,000USD | -653,836USD | -525,359USD | -199,916USD | -489,100USD | — |
| Sale Purchase Of Stock | — | -549,000USD | -150,000USD | 0USD | — | -36,000USD | -375,000USD | — |
| Other Cashflows From Investing Activities | — | 3,000USD | 34,000USD | — | — | — | — | — |
| Change To Liabilities | — | — | — | 1,124,085USD | 30,229USD | 1,121,340USD | -962USD | — |
| Change To Account Receivables | — | — | — | — | — | 440,000USD | -333,000USD | 180,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
No revenue breakdown is currently published for this company.
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.